Laddr
Commercial- Indications
- Depression, Alcohol use disorder, Substance use disorder
Company intelligence / Profile preview
Square2 Systems has developed and clinically validated digital therapeutics for behavior change. Their tools—including Laddr—have demonstrated efficacy in multiple large randomized controlled trials for substance use disorders and other health behaviors. The company’s technology has won awards such as the 2021 National Academy of Medicine of Colombia award for a national study with Laddr. Earlier work includes TES, a computerized behavior therapy program shown to be as effective as clinician-delivered therapy in opioid dependence
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Square2 Systems.